LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 11

Search options

  1. Article ; Online: Palladium-Catalyzed Esterification of Carboxylic Acids with Aryl Iodides.

    Kitano, Hiroyuki / Ito, Hideto / Itami, Kenichiro

    Organic letters

    2018  Volume 20, Issue 8, Page(s) 2428–2432

    Abstract: The first palladium-catalyzed esterification of carboxylic acids with aryl iodides is described. A palladium-based catalytic system consisting of ... ...

    Abstract The first palladium-catalyzed esterification of carboxylic acids with aryl iodides is described. A palladium-based catalytic system consisting of IBn
    Language English
    Publishing date 2018--20
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1523-7052
    ISSN (online) 1523-7052
    DOI 10.1021/acs.orglett.8b00775
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Annulative π-extension of indoles and pyrroles with diiodobiaryls by Pd catalysis: rapid synthesis of nitrogen-containing polycyclic aromatic compounds.

    Kitano, Hiroyuki / Matsuoka, Wataru / Ito, Hideto / Itami, Kenichiro

    Chemical science

    2018  Volume 9, Issue 38, Page(s) 7556–7561

    Abstract: A palladium-catalyzed one-step annulative π-extension (APEX) reaction of indoles and pyrroles that allows rapid access to nitrogen-containing polycyclic aromatic compounds is described. In the presence of palladium pivalate and silver carbonate, diverse ... ...

    Abstract A palladium-catalyzed one-step annulative π-extension (APEX) reaction of indoles and pyrroles that allows rapid access to nitrogen-containing polycyclic aromatic compounds is described. In the presence of palladium pivalate and silver carbonate, diverse indoles or pyrroles coupled with diiodobiaryls in a double direct C-H arylation manner to be transformed into the corresponding π-extended compounds in a single step. The newly developed catalytic system enables the use of various pyrroles and indoles as templates with a series of diiodobiaryls to provide structurally complicated and largely π-extended nitrogen-containing polycyclic aromatic compounds that are otherwise difficult to synthesize.
    Language English
    Publishing date 2018-08-09
    Publishing country England
    Document type Journal Article
    ZDB-ID 2559110-1
    ISSN 2041-6539 ; 2041-6520
    ISSN (online) 2041-6539
    ISSN 2041-6520
    DOI 10.1039/c8sc02802h
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Palladium-Catalyzed Esterification of Carboxylic Acids with Aryl Iodides

    Kitano, Hiroyuki / Hideto Ito / Kenichiro Itami

    Organic letters. 2018 Apr. 04, v. 20, no. 8

    2018  

    Abstract: The first palladium-catalyzed esterification of carboxylic acids with aryl iodides is described. A palladium-based catalytic system consisting of IBnF (1,3-bis((pentafluorophenyl)methyl)imidazole-2-ylidene) ligand was found to significantly accelerate ... ...

    Abstract The first palladium-catalyzed esterification of carboxylic acids with aryl iodides is described. A palladium-based catalytic system consisting of IBnF (1,3-bis((pentafluorophenyl)methyl)imidazole-2-ylidene) ligand was found to significantly accelerate the aryl–O bond-forming esterification reaction. A series of aryl iodides and carboxylic acids undergoes a palladium-catalyzed coupling reaction to provide the corresponding aryl esters in moderate to good yields. In addition, sterically hindered aryl iodides and carboxylic acids were well-tolerated yielding the corresponding aryl esters.
    Keywords carboxylic acids ; catalytic activity ; chemical structure ; esterification ; esters ; ligands ; organoiodine compounds ; palladium
    Language English
    Dates of publication 2018-0404
    Size p. 2428-2432.
    Publishing place American Chemical Society
    Document type Article
    ISSN 1523-7052
    DOI 10.1021/acs.orglett.8b00775
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  4. Article ; Online: Surgical Outcomes of Biventricular Repair for Hypoplastic Left Ventricle With Congenital Mitral Valve Stenosis.

    Shimada, Masatoshi / Hoashi, Takaya / Nakata, Tomohiro / Ozawa, Hideto / Kurosaki, Kenichi / Kitano, Masataka / Ichikawa, Hajime

    World journal for pediatric & congenital heart surgery

    2019  Volume 10, Issue 1, Page(s) 11–17

    Abstract: Objective: Surgical outcomes of biventricular repair for hearts with hypoplastic left ventricle with congenital mitral valve stenosis are described. Serial changes of left ventricular geometry and clinical features after biventricular repair were ... ...

    Abstract Objective: Surgical outcomes of biventricular repair for hearts with hypoplastic left ventricle with congenital mitral valve stenosis are described. Serial changes of left ventricular geometry and clinical features after biventricular repair were reviewed.
    Methods: Eight patients with hypoplastic left ventricle and congenital mitral valve stenosis who underwent first surgical intervention for biventricular circulation in neonatal or infantile period between 2001 and 2014 comprise the study population. Serial change in left ventricular end-diastolic diameter, left ventricular mass index, and relative wall thickness after biventricular repair were evaluated by two-dimensional echocardiography.
    Results: The median Z-scores of left ventricular end-diastolic diameter and mitral valve diameter before the first surgical intervention were -3.0 (range, -4.8 to -2.0) and -1.0 (-2.9 to 2.1), respectively. Mitral valves were surgically treated in five patients; they were replaced in two and repaired in three patients. Left ventricular end-diastolic diameter Z-score at five years after biventricular repair was 0.1 (-3.0 to 1.0), which was significantly larger than before first surgical intervention ( P = .005). Left ventricular mass index, on the other hand, did not change, but relative wall thickness significantly decreased ( P = .009). Postoperative catheter study showed pulmonary hypertension with high left ventricular end-diastolic pressure in more than half of survivors.
    Conclusions: Left ventricle increased in size after the biventricular repair with appropriate mitral valve procedures before progression of pulmonary hypertension. Left ventricular mass, however, did not accompany the increase. Some patients may have suffered from mild, but certain restrictive left ventricular physiology and subsequent pulmonary hypertension as the result of abnormal remodeling process of the myocardium.
    MeSH term(s) Abnormalities, Multiple ; Cardiac Surgical Procedures/methods ; Echocardiography ; Female ; Heart Ventricles/abnormalities ; Heart Ventricles/diagnostic imaging ; Heart Ventricles/surgery ; Humans ; Hypoplastic Left Heart Syndrome/diagnosis ; Hypoplastic Left Heart Syndrome/surgery ; Infant ; Infant, Newborn ; Male ; Mitral Valve/diagnostic imaging ; Mitral Valve/surgery ; Mitral Valve Stenosis/congenital ; Mitral Valve Stenosis/diagnosis ; Mitral Valve Stenosis/surgery ; Treatment Outcome
    Language English
    Publishing date 2019-03-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2550261-X
    ISSN 2150-136X ; 2150-1351
    ISSN (online) 2150-136X
    ISSN 2150-1351
    DOI 10.1177/2150135118808748
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Discovery of Plant Growth Stimulants by C–H Arylation of 2-Azahypoxanthine

    Kitano, Hiroyuki / Ayaka Ueda / Hideto Ito / Hirokazu Kawagishi / Jae-Hoon Choi / Kenichiro Itami / Shinya Hagihara / Toshiyuki Kan

    Organic letters. 2018 Sept. 04, v. 20, no. 18

    2018  

    Abstract: A series of new AHX derivatives were synthesized by Pd-catalyzed C–H arylation. Their rice-growth-promoting activity was evaluated in vivo. Among the synthesized compounds, C8 phenyl-substituted AHX showed remarkable growth-promoting activity on rice. ... ...

    Abstract A series of new AHX derivatives were synthesized by Pd-catalyzed C–H arylation. Their rice-growth-promoting activity was evaluated in vivo. Among the synthesized compounds, C8 phenyl-substituted AHX showed remarkable growth-promoting activity on rice. The present study shows the power and significant opportunity of C–H functionalization chemistry to rapidly transform biologically active natural products into more active compounds.
    Keywords active ingredients ; arylation ; carbon-hydrogen bond activation ; catalytic activity ; chemical structure ; organic compounds ; palladium ; rice
    Language English
    Dates of publication 2018-0904
    Size p. 5684-5687.
    Publishing place American Chemical Society
    Document type Article
    ISSN 1523-7052
    DOI 10.1021/acs.orglett.8b02407
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  6. Article ; Online: Discovery of Plant Growth Stimulants by C-H Arylation of 2-Azahypoxanthine.

    Kitano, Hiroyuki / Choi, Jae-Hoon / Ueda, Ayaka / Ito, Hideto / Hagihara, Shinya / Kan, Toshiyuki / Kawagishi, Hirokazu / Itami, Kenichiro

    Organic letters

    2018  Volume 20, Issue 18, Page(s) 5684–5687

    Abstract: A series of new AHX derivatives were synthesized by Pd-catalyzed C-H arylation. Their rice-growth-promoting activity was evaluated in vivo. Among the synthesized compounds, C8 phenyl-substituted AHX showed remarkable growth-promoting activity on rice. ... ...

    Abstract A series of new AHX derivatives were synthesized by Pd-catalyzed C-H arylation. Their rice-growth-promoting activity was evaluated in vivo. Among the synthesized compounds, C8 phenyl-substituted AHX showed remarkable growth-promoting activity on rice. The present study shows the power and significant opportunity of C-H functionalization chemistry to rapidly transform biologically active natural products into more active compounds.
    Language English
    Publishing date 2018-09-04
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1523-7052
    ISSN (online) 1523-7052
    DOI 10.1021/acs.orglett.8b02407
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome.

    Ishihara, Mikiya / Kitano, Shigehisa / Kageyama, Shinichi / Miyahara, Yoshihiro / Yamamoto, Noboru / Kato, Hidefumi / Mishima, Hideyuki / Hattori, Hiroyoshi / Funakoshi, Takeru / Kojima, Takashi / Sasada, Tetsuro / Sato, Eiichi / Okamoto, Sachiko / Tomura, Daisuke / Nukaya, Ikuei / Chono, Hideto / Mineno, Junichi / Kairi, Muhammad Faris / Diem Hoang Nguyen, Phuong /
    Simoni, Yannick / Nardin, Alessandra / Newell, Evan / Fehlings, Michael / Ikeda, Hiroaki / Watanabe, Takashi / Shiku, Hiroshi

    Journal for immunotherapy of cancer

    2022  Volume 10, Issue 6

    Abstract: Background: Because of the shortage of ideal cell surface antigens, the development of T-cell receptor (TCR)-engineered T cells (TCR-T) that target intracellular antigens such as NY-ESO-1 is a promising approach for treating patients with solid tumors. ... ...

    Abstract Background: Because of the shortage of ideal cell surface antigens, the development of T-cell receptor (TCR)-engineered T cells (TCR-T) that target intracellular antigens such as NY-ESO-1 is a promising approach for treating patients with solid tumors. However, endogenous TCRs in vector-transduced T cells have been suggested to impair cell-surface expression of transduced TCR while generating mispaired TCRs that can become self-reactive.
    Methods: We conducted a first-in-human phase I clinical trial with the TCR-transduced T-cell product (TBI-1301) in patients with NY-ESO-1-expressing solid tumors. In manufacturing TCR-T cells, we used a novel affinity-enhanced NY-ESO-1-specific TCR that was transduced by a retroviral vector that enables siRNA (small interfering RNA)-mediated silencing of endogenous TCR. The patients were divided into two cohorts. Cohort 1 was given a dose of 5×10
    Results: In vitro study showed that both the CD8
    Conclusions: The trial showed that endogenous TCR-silenced and affinity-enhanced NY-ESO-1 TCR-T cells were safely administered except for grade 3 lung injury. The TCR-T cell infusion exhibited significant tumor response and early-onset CRS in patients with tumors that express NY-ESO-1 at high levels. The differentiation properties of the manufactured T cells may be prognostic for TCR-T-related CRS.
    Trial registration number: NCT02366546.
    MeSH term(s) Antigens, Neoplasm ; Cyclophosphamide ; Cytokine Release Syndrome/therapy ; Cytokines/metabolism ; Humans ; Immunotherapy ; Membrane Proteins ; Neoplasms/immunology ; Neoplasms/therapy ; Receptors, Antigen, T-Cell/genetics ; T-Lymphocytes/immunology
    Chemical Substances Antigens, Neoplasm ; CTAG1B protein, human ; Cytokines ; Membrane Proteins ; Receptors, Antigen, T-Cell ; Cyclophosphamide (8N3DW7272P)
    Language English
    Publishing date 2022-06-29
    Publishing country England
    Document type Clinical Trial, Phase I ; Journal Article
    ZDB-ID 2719863-7
    ISSN 2051-1426 ; 2051-1426
    ISSN (online) 2051-1426
    ISSN 2051-1426
    DOI 10.1136/jitc-2021-003811
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Application of hybrid Stage I palliation for patients with two ventricular cavities and hypoplastic left heart structures.

    Higashida, Akihiko / Hoashi, Takaya / Kitano, Masataka / Shimada, Masatoshi / Nakata, Tomohiro / Ozawa, Hideto / Kurosaki, Kenichi / Ichikawa, Hajime

    Interactive cardiovascular and thoracic surgery

    2017  Volume 26, Issue 6, Page(s) 906–911

    Abstract: Objectives: To assess the feasibility of hybrid Stage I palliation consisting of bilateral pulmonary artery bandings and ductal stenting for patients with 2 ventricular cavities and hypoplastic left heart structures.: Methods: Eleven consecutive ... ...

    Abstract Objectives: To assess the feasibility of hybrid Stage I palliation consisting of bilateral pulmonary artery bandings and ductal stenting for patients with 2 ventricular cavities and hypoplastic left heart structures.
    Methods: Eleven consecutive patients who underwent hybrid Stage I palliation between 2010 and 2017 were enrolled. The diagnoses were interrupted aortic arch/coarctation of the aorta, ventricular septal defect and significant left ventricular (LV) outflow tract obstruction in 5 patients, critical aortic stenosis and reduced LV contraction in 3 patients and hypoplastic left heart complex in 3 patients.
    Results: The median age at definitive surgery was 12 months (range 6-22 months). During the mean follow-up period of 24 months (range 9-83 months) following the definitive surgery, there was 1 death. Two patients with interrupted aortic arch/coarctation of the aorta did not undergo the Yasui operation but underwent arch repair and ventricular septal defect closure after the growth of the aortic valve and LV outflow tract. For 2 of the 3 patients with critical aortic stenosis, biventricular repair was performed. Of the 3 patients with hypoplastic left heart complex, 2 patients showed growth of the mitral valve and left ventricle following LV rehabilitation by balloon pulmonary artery dilatation or surgical debanding of the banded pulmonary arteries and subsequently underwent biventricular repair, which resulted in 1 death.
    Conclusions: Hybrid Stage I palliation would be a safe and beneficial treatment for patients with 2 ventricles, as a bridge to decide whether and how to achieve a biventricular repair and whether it should be preceded by a preliminary LV rehabilitation.
    MeSH term(s) Aortic Coarctation/surgery ; Aortic Valve Stenosis/surgery ; Female ; Heart Septal Defects, Ventricular/surgery ; Heart Ventricles/abnormalities ; Humans ; Hypoplastic Left Heart Syndrome/surgery ; Infant ; Male ; Palliative Care ; Stents ; Vascular Surgical Procedures/methods
    Language English
    Publishing date 2017-12-02
    Publishing country England
    Document type Journal Article
    ZDB-ID 2095298-3
    ISSN 1569-9285 ; 1569-9293
    ISSN (online) 1569-9285
    ISSN 1569-9293
    DOI 10.1093/icvts/ivx428
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Estradiol attenuates neuroprotective benefits of isoflurane preconditioning in ischemic mouse brain.

    Wang, Lan / Kitano, Hideto / Hurn, Patricia D / Murphy, Stephanie J

    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

    2008  Volume 28, Issue 11, Page(s) 1824–1834

    Abstract: Isoflurane preconditioning (IsoPC) neuroprotection in experimental stroke is male-specific. We determined whether estradiol alters ischemic outcomes in IsoPC brain and examined the role of estrogen receptors (ERs). Seven to 10 days before preconditioning, ...

    Abstract Isoflurane preconditioning (IsoPC) neuroprotection in experimental stroke is male-specific. We determined whether estradiol alters ischemic outcomes in IsoPC brain and examined the role of estrogen receptors (ERs). Seven to 10 days before preconditioning, ovariectomized (OVX) mice were implanted with estradiol, vehicle, or ER subtype agonists. OVX+/-estradiol, OVX+/-vehicle, OVX+/-ER agonists, and ER subtype wild-type (WT) and knockout (KO) mice were preconditioned for 4 h with sham anesthetic preconditioning (sham PC) or 1% IsoPC and recovered for 24 h. Mice then underwent 2 h of middle cerebral artery occlusion followed by 22 h of reperfusion. Infarct volumes were determined by 2,3,5-triphenyltetrazolium chloride staining, with comparisons between IsoPC and corresponding sham PC for each treatment group. Decreased infarct injury was seen in IsoPC OVX+/-vehicle, whereas estradiol in IsoPC OVX mice enhanced ischemic damage. In ER studies, increased infarct volumes were seen in IsoPC ERWT mice regardless of ER subtype. IsoPC in ERalphaKO mice had no effect on infarction volume but reduced only cortical ischemic damage in ERbetaKO mice. In OVX+ERalpha agonist, IsoPC had no effect on infarction volume. In OVX+ERbeta agonist, IsoPC increased cortical infarct volume. Estradiol depresses the brain's protective response to IsoPC and may exacerbate cortical ischemic injury mainly through an ERbeta-dependent mechanism.
    MeSH term(s) Animals ; Brain Ischemia/genetics ; Brain Ischemia/physiopathology ; Disease Models, Animal ; Drug Implants ; Estradiol/administration & dosage ; Estradiol/pharmacology ; Estrogen Receptor alpha/deficiency ; Estrogen Receptor beta/genetics ; Female ; Ischemic Attack, Transient/genetics ; Ischemic Attack, Transient/physiopathology ; Ischemic Preconditioning/methods ; Isoflurane/pharmacology ; Mice ; Mice, Knockout ; Neuroprotective Agents/antagonists & inhibitors ; Ovariectomy ; Receptors, Estrogen/deficiency ; Receptors, Estrogen/genetics ; Receptors, Estrogen/physiology ; Sex Characteristics
    Chemical Substances Drug Implants ; Estrogen Receptor alpha ; Estrogen Receptor beta ; Neuroprotective Agents ; Receptors, Estrogen ; Estradiol (4TI98Z838E) ; Isoflurane (CYS9AKD70P)
    Language English
    Publishing date 2008-07-09
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 604628-9
    ISSN 1559-7016 ; 0271-678X
    ISSN (online) 1559-7016
    ISSN 0271-678X
    DOI 10.1038/jcbfm.2008.70
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain.

    Kitano, Hideto / Kirsch, Jeffrey R / Hurn, Patricia D / Murphy, Stephanie J

    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

    2007  Volume 27, Issue 6, Page(s) 1108–1128

    Abstract: This review will focus on inhalational anesthetic neuroprotection during cerebral ischemia and inhalational anesthetic preconditioning before ischemic brain injury. The limitations and challenges of past and current research in this area will be ... ...

    Abstract This review will focus on inhalational anesthetic neuroprotection during cerebral ischemia and inhalational anesthetic preconditioning before ischemic brain injury. The limitations and challenges of past and current research in this area will be addressed before reviewing experimental and clinical studies evaluating the effects of inhalational anesthetics before and during cerebral ischemia. Mechanisms underlying volatile anesthetic neuroprotection and preconditioning will also be examined. Lastly, future directions for inhalational anesthetics and ischemic brain injury will be briefly discussed.
    MeSH term(s) Anesthetics, Inhalation/pharmacology ; Anesthetics, Inhalation/therapeutic use ; Brain Ischemia/drug therapy ; Humans ; Ischemic Preconditioning/methods ; Neuroprotective Agents/therapeutic use
    Chemical Substances Anesthetics, Inhalation ; Neuroprotective Agents
    Language English
    Publishing date 2007-06
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 604628-9
    ISSN 1559-7016 ; 0271-678X
    ISSN (online) 1559-7016
    ISSN 0271-678X
    DOI 10.1038/sj.jcbfm.9600410
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top